Institutional agreement
The institution accepts MDA data, confidentiality, security, publication, conflict, closeout, and remedy terms.
Institution-sponsored pathway
Bring your institution into the agreement before data or inventive work begins.
For researchers whose university, hospital, institute, government laboratory, nonprofit, company, sponsor, or employer may approve the work or claim rights in data, inventions, software, publications, or commercial outcomes.
What you bring
A focused question, scientific leadership, and an authorized institution.
The researcher supplies expertise and a credible plan. The institution confirms authority to participate and identifies the people responsible for contracting, privacy, research compliance, and technology transfer.
A named principal investigator and project team.
Institutional approval and an authorized signatory.
IRB or ethics status, funding and sponsor information, and required assurances.
Disclosure of background IP, employment obligations, conflicts, tools, collaborators, and proposed publications.
Before access
MDA and the institution establish the operating boundary.
Data-use schedule
Each question receives a minimum-necessary dataset, named users, approved workspace, purpose, term, export controls, and closeout duties.
Project IP schedule
Background IP stays identified. Project IP, patent control, costs, licensing economics, and spinout rights are documented before inventive work.
Independent oversight
Scientific validation, privacy and ethics review, conflict management, and transaction approval stay separate from personal financial interests.
Researcher value
Institutional rigor with a direct path to realized outcomes.
Researchers receive patient-informed feasibility, governed data support, attribution and publication pathways, and a translational route without building community and consent infrastructure from zero.
Approved outputs earn 2,250-10,000 credits, with planning-value targets from $22,500 to $100,000.
The credits and dollar targets describe one outcome-participation system—not two awards and not a promised fixed percentage.
Separately documented patent and licensing economics.
A possible time-limited opportunity to propose, help form, or join an approved spinout.
Potential founder equity, options, consulting, employment, or other economics only under definitive agreements.
The operating rule
No authorized institution agreement, no nonpublic data access. No written Project IP arrangement, no inventive work. No separate license, no commercial rights.